Digest Network Come funziona
Network
/
Società
Sc
Non verificato

Scholar Rock

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieMercato azionarioSalute

57 comunicati stampa

Guarda tutti i comunicati
18/11/2025
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Eventi
Scholar Rock to Present at Upcoming Investor Conferences
Fonte
Scholar Rock
Emittente
Business Wire
1.00
0
14/11/2025
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Web e Social Network
Telefonia e Varie
Mercato azionario
Scholar Rock Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Fonte
Scholar Rock
Emittente
Business Wire
1.00
0
12/11/2025
Mercato azionario
Salute
Scienza
Farmaceutica
Biotecnologia
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Scholar Rock
Emittente
Business Wire
1.00
0
04/11/2025
Web e Social Network
Eventi
Salute
Biotecnologia
Sanità
Scienza
Farmaceutica
Scholar Rock to Present at the 2025 Jefferies Global Healthcare Conference
Fonte
Scholar Rock
Emittente
Business Wire
1.00
0
23/10/2025
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Scholar Rock to Report Third Quarter 2025 Financial Results on November 14, 2025
Fonte
Scholar Rock
Emittente
Business Wire
1.00
0
17/10/2025
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Mercato azionario
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Scholar Rock
Emittente
Business Wire
1.00
0
23/09/2025
Industria
Igiene alimentare
Biotecnologia
Sanità
Salute
Farmaceutica
FDA Issues Complete Response Letter (CRL) for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA) Solely Related to Observations Identified at Catalent Indiana LLC Fill-Finish Facility
Fonte
Scholar Rock
Emittente
Business Wire
1.00
0
12/09/2025
Salute
Biotecnologia
Scienza
Farmaceutica
Mercato azionario
Finanza
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Scholar Rock
Emittente
Business Wire
1.00
0
15/08/2025
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Mercato azionario
Finanza
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Scholar Rock
Emittente
Business Wire
1.00
0
14/08/2025
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Medicina - Varie
Industria
Pivotal SAPPHIRE Trial Data Published in The Lancet Neurology: Apitegromab Demonstrated Significant Motor Function Gains for Children and Adults with SMA on SMN-Targeted Treatment
Fonte
Scholar Rock
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0